Modulation of Striatal Dopamine Release by Glycine Transport Inhibitors

This publication has 64 references indexed in Scilit:

• Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In Vivo
  Journal of Neurophysiology, 2003
• Subchronic Continuous Phencyclidine Administration Potentiates Amphetamine-Induced Frontal Cortex Dopamine Release
  Neuropsychopharmacology, 2003
• Continuous Phencyclidine Treatment Induces Schizophrenia-Like Hyperreactivity of Striatal Dopamine Release
  Neuropsychopharmacology, 2001
• Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [¹²³I]Iomazenil
  American Journal of Psychiatry, 1998
• The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
  Pharmacopsychiatry, 1998
• Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
  Synapse, 1998
• Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
  Proceedings of the National Academy of Sciences, 1997
• GABAB receptor activation partially inhibits N-methyl-D-aspartate-mediated tyrosine hydroxylase stimulation in rat striatal slices
  European Journal of Pharmacology, 1992
• γ-Aminobutyric acid (GABAB) receptor-mediated inhibition of tyrosine hydroxylase activity in the striatum of rat
  Neuropharmacology, 1991
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
  Trends in Neurosciences, 1990